BNP Paribas Arbitrage SA raised its stake in Humana Inc. (NYSE:HUM) by 86.3% during the third quarter, Holdings Channel reports. The institutional investor owned 20,317 shares of the insurance provider’s stock after buying an additional 9,414 shares during the period. BNP Paribas Arbitrage SA’s holdings in Humana were worth $3,594,000 at the end of the most recent quarter.

Other hedge funds have also made changes to their positions in the company. Point72 Asia Hong Kong Ltd acquired a new stake in shares of Humana during the second quarter valued at $126,000. Daiwa SB Investments Ltd. increased its stake in shares of Humana by 7.5% in the second quarter. Daiwa SB Investments Ltd. now owns 720 shares of the insurance provider’s stock valued at $132,000 after buying an additional 50 shares in the last quarter. Bessemer Group Inc. increased its stake in shares of Humana by 14.0% in the second quarter. Bessemer Group Inc. now owns 1,140 shares of the insurance provider’s stock valued at $205,000 after buying an additional 140 shares in the last quarter. BB&T Securities LLC increased its stake in shares of Humana by 13.6% in the second quarter. BB&T Securities LLC now owns 1,374 shares of the insurance provider’s stock valued at $247,000 after buying an additional 165 shares in the last quarter. Finally, Sterling Capital Management LLC acquired a new stake in shares of Humana during the second quarter valued at $251,000. Institutional investors and hedge funds own 91.71% of the company’s stock.

Institutional Ownership by Quarter for Humana (NYSE:HUM)

Shares of Humana Inc. (NYSE:HUM) traded up 0.96% on Tuesday, reaching $210.00. The company’s stock had a trading volume of 1,732,240 shares. The company’s 50 day moving average price is $182.87 and its 200 day moving average price is $177.74. Humana Inc. has a 12-month low of $150.00 and a 12-month high of $211.71. The company has a market cap of $31.31 billion, a P/E ratio of 28.40 and a beta of 0.80.

Humana (NYSE:HUM) last announced its quarterly earnings data on Friday, November 4th. The insurance provider reported $3.18 earnings per share for the quarter, beating the Zacks’ consensus estimate of $3.09 by $0.09. Humana had a net margin of 2.00% and a return on equity of 12.32%. The business had revenue of $13.69 billion for the quarter, compared to analyst estimates of $13.41 billion. During the same period last year, the business earned $2.16 EPS. The company’s revenue was up 2.5% on a year-over-year basis. Analysts forecast that Humana Inc. will post $9.51 EPS for the current fiscal year.

The company also recently disclosed a quarterly dividend, which will be paid on Friday, January 27th. Stockholders of record on Thursday, January 12th will be issued a $0.29 dividend. The ex-dividend date is Tuesday, January 10th. This represents a $1.16 dividend on an annualized basis and a dividend yield of 0.55%. Humana’s payout ratio is 15.96%.

ILLEGAL ACTIVITY NOTICE: “BNP Paribas Arbitrage SA Raises Stake in Humana Inc. (HUM)” was posted by Financial Market News and is the propert of of Financial Market News. If you are accessing this story on another website, it was stolen and reposted in violation of US and international trademark & copyright legislation. The correct version of this story can be accessed at http://www.financial-market-news.com/bnp-paribas-arbitrage-sa-raises-stake-in-humana-inc-hum/1209122/.

Several analysts recently weighed in on HUM shares. Zacks Investment Research upgraded Humana from a “hold” rating to a “buy” rating and set a $198.00 price objective for the company in a research report on Tuesday, October 4th. Evercore ISI started coverage on Humana in a report on Thursday, September 22nd. They issued a “buy” rating and a $200.00 target price for the company. Jefferies Group reaffirmed a “buy” rating and issued a $206.00 target price on shares of Humana in a report on Monday, November 7th. Cantor Fitzgerald reaffirmed a “buy” rating on shares of Humana in a report on Monday, August 8th. Finally, Barclays PLC lowered their target price on Humana from $193.00 to $191.00 and set an “equal weight” rating for the company in a report on Thursday, August 4th. Five equities research analysts have rated the stock with a hold rating and eleven have assigned a buy rating to the stock. Humana has a consensus rating of “Buy” and an average target price of $205.00.

About Humana

Humana Inc is a health and well-being company. The Company’s segments include Retail, Group, Healthcare Services and Other Businesses. The Retail segment consists of Medicare benefits, marketed to individuals or directly via group accounts, as well as individual commercial fully-insured medical and specialty health insurance benefits, including dental, vision, and other supplemental health and financial protection products.

5 Day Chart for NYSE:HUM

Want to see what other hedge funds are holding HUM? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Humana Inc. (NYSE:HUM).

Receive News & Ratings for Humana Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Humana Inc. and related companies with MarketBeat.com's FREE daily email newsletter.